This product is supplied exclusively for in-vitro laboratory research use. It is not intended for human or animal use, including diagnosis, treatment, mitigation, or prevention of disease.
Retatrutide 5mg
$95Purity: 99.343%
Independently Tested
Freedom Diagnostics — USA Lab
Product ID
RETATRUTIDE
Purity
99.343%
Dosage
5mg
Category
Weight Loss
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight | 4,731 Da |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-αMeLeu-Leu-Asp-Lys-Lys-Ala-Gln-Ala-Aib-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser |
| CAS Number | 2381089-83-2 ↗ |
| Purity | 99.343% HPLC |
| Form | Lyophilized Powder |
| Storage | -20°C / -4°F |
Tested by Freedom Diagnostics
HPLC + Mass Spectrometry · USA Lab
About Retatrutide
Retatrutide is a breakthrough triple agonist peptide that simultaneously targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and GCG (glucagon) receptors — making it the most comprehensive incretin-based research tool currently available. This 39-amino acid synthetic peptide represents the cutting edge of metabolic peptide research, enabling scientists to study the combined effects of all three incretin/counterregulatory hormone pathways in a single compound.
The glucagon receptor component distinguishes Retatrutide from dual agonists like Tirzepatide. GCG receptor activation promotes hepatic glucose output and fatty acid oxidation, enhancing energy expenditure in preclinical models. When combined with GIP and GLP-1 activity, the net effect in animal studies has shown significant reductions in body weight and adiposity beyond what dual agonists achieve.
Research-grade Retatrutide at 5mg/vial from Pure Pharm Peptides is verified at 99.343% purity, providing researchers with a reliable tool for investigating the frontier of metabolic peptide pharmacology.
Research Applications:
- Triple incretin receptor signaling pathway studies
- Hepatic glucose metabolism and fatty acid oxidation research
- Comparative dual vs. triple agonist metabolic effect studies
- Energy expenditure and thermogenesis investigations
- Adipose tissue reduction mechanisms in preclinical models
- Non-alcoholic fatty liver disease (NAFLD) model research
Key Specifications:
- Purity: 99.343% verified by Freedom Diagnostics testing
- Dosage: 5mg per vial
- Category: Weight Loss
- Storage: -20°C or colder (lyophilized)
- Stability: Up to 2 years when stored properly
Research Highlights:
- World's first triple GIP/GLP-1/GCG receptor agonist available for research
- 99.343% purity verified by Freedom Diagnostics HPLC analysis
- Glucagon receptor component drives hepatic fat oxidation and energy expenditure
- Enables comparison of dual vs. triple agonist metabolic effects
- Molecular weight: 4,731 Da | CAS: 2381089-83-2 | PubChem CID: 171390338
Retatrutide 5mg
Retatrutide is the newest breakthrough in weight loss research, targeting three different pathways (a 'triple agonist'). Early studies show it may be the most powerful option yet for significant weight reduction, making it highly sought after by researchers exploring cutting-edge metabolic therapies.
Frequently Asked Questions — Retatrutide
Customer Reviews
No reviews yet
Share & Earn Rewards
Earn $10 when someone buys through your link!
We Accept
Zelle
CryptoMore Options via EmailPayPal, Cash App & more available — select "More Payment Options" at checkout.
Share:
Frequently Researched Together
Stay Updated on Research Peptides
Get exclusive updates on new products, COA releases, and research insights delivered to your inbox.
The verified choice for researchers who demand proof, not just claims. Tested by Freedom Diagnostics.
For research purposes only.
Company
Contact
Freedom Diagnostics
Accredited USA Laboratory
WE ACCEPT
© 2026 Pure Pharm Peptides. All rights reserved.
Retatrutide
$95